January 19, 2024

Accrol Group Investment Case Upside Analysed Post Severn Delta Acquisition by Shore Capital

Tom Fraine, Equity Analyst at Shore Capital, analyzes Accrol Group Holdings' acquisition of Severn Delta. He highlights the positive business potential and strategic growth opportunities for the company. The planned self-funded investment in a paper mill is expected to drive further margin increases. Accrol's strong performance, low capex requirements, and favorable market conditions position it for continued success...

XP Factory CEO Richard Harpham Talks Remarkable Growth and Strategic Insights (VIDEO)

Discover the remarkable growth and strategic insights of XP Factory plc as CEO Richard Harpham discusses their financial success and future plans...

4imprint Group Strong Financial Performance for 2023 and Confident Outlook

4imprint, the leading promotional products marketer, will announce its final results for 2023, showcasing strong financial performance and growth...

Petershill Partners gross fee-eligible AuM raise of US$23 billion in 2023

Petershill Partners plc has released its 2023 AuM Update and AuM outlook for 2024, showing steady growth and positive performance...

Syncona’s portfolio company, Freeline, releases positive data on gene therapy for Gaucher disease

Syncona Ltd notes further safety and enzyme activity data from its portfolio company, Freeline Therapeutics, on its gene therapy candidate for Gaucher disease...

Versarien raises £400,000 for corporate and working capital purposes

Versarien plc has raised £400,000 through a placing of new shares, with the net proceeds to be used for capital purposes and seizing growth opportunities...

N4 Pharma’s Nuvec® granted patent in India

N4 Pharma Plc announces the granting of a patent for its Nuvec® delivery system in India, adding to its global portfolio of granted patents...
Search

Funds

PLC News

Accrol Group Investment Case Upside Analysed Post Severn Delta Acquisition by Shore Capital

Tom Fraine, Equity Analyst at Shore Capital, analyzes Accrol Group Holdings' acquisition of Severn Delta. He highlights the positive business potential and strategic growth opportunities for the company. The planned self-funded investment in a paper mill is expected to drive further margin increases. Accrol's strong performance, low capex requirements, and favorable market conditions position it for continued success...

XP Factory CEO Richard Harpham Talks Remarkable Growth and Strategic Insights (VIDEO)

Discover the remarkable growth and strategic insights of XP Factory plc as CEO Richard Harpham discusses their financial success and future plans...

4imprint Group Strong Financial Performance for 2023 and Confident Outlook

4imprint, the leading promotional products marketer, will announce its final results for 2023, showcasing strong financial performance and growth...

Petershill Partners gross fee-eligible AuM raise of US$23 billion in 2023

Petershill Partners plc has released its 2023 AuM Update and AuM outlook for 2024, showing steady growth and positive performance...

Syncona’s portfolio company, Freeline, releases positive data on gene therapy for Gaucher disease

Syncona Ltd notes further safety and enzyme activity data from its portfolio company, Freeline Therapeutics, on its gene therapy candidate for Gaucher disease...

Versarien raises £400,000 for corporate and working capital purposes

Versarien plc has raised £400,000 through a placing of new shares, with the net proceeds to be used for capital purposes and seizing growth opportunities...

N4 Pharma’s Nuvec® granted patent in India

N4 Pharma Plc announces the granting of a patent for its Nuvec® delivery system in India, adding to its global portfolio of granted patents...
Search

Funds

January 19, 2024

FTSE 100

Funds